Stock Price

As surging oil prices and elevated yields trigger a historic market split, traditional defense and industrial sectors are seizing the spotlight.

Despite recent clinical setbacks, Alector's $75 million premium offering signals strong institutional faith in its blood-brain barrier technology.

A devastating congressional report has triggered a class action against Webull, exposing the severe risks of masking Chinese operations as American fintech.

Jeffrey Tirman brings 35 years of restructuring expertise to Datavault AI, signaling a critical shift from aggressive expansion to financial stabilization.

Faraday Future is spinning off its robotics unit into a former crypto shell. We explore the governance risks and reality behind the ambitious AI hype.

The clinical-stage biotech's public debut tests investor appetite for immunology as it funds a novel Treg pipeline into 2029.

As Liberty Defense transitions from R&D to scaling its AI-powered weapons detection tech, COO Keith Teichmann steps up as Interim CEO to drive growth.

Bumble is going private in a $1.3 billion buyout by Ithaca Holdings. The deal ends its turbulent public run and bets on AI to revive the dating app market.

Ahead of its Q2 fiscal 2027 earnings report, Deckers Brands leans on the dual-engine momentum of HOKA and UGG to navigate consumer spending headwinds.

After a high-profile Phase 2 trial failure in pulmonary fibrosis, Syndax narrows its strategic focus to maximize its established cGVHD partnership with Incyte.

As Christian Dior posts a mere 1% Q3 organic growth, a deep dive reveals how shedding assets and shifting focus are the new playbook for luxury survival.

Evernorth debuts on the Nasdaq with a new CIO to lead its active XRP treasury, but a quiet SEC filing correction reveals unexpected equity dilution.

A recent Nasdaq deficiency notice for Singapore's CytoMed Therapeutics highlights the intense market pressures facing pre-revenue biotechs today.

CrowdStrike’s latest battle with an offshore LLC highlights the hidden dangers of mini-tender offers and the regulatory gaps threatening retail investors.

East Side Games Group has swapped legacy debt for government-backed export financing. Helen Davis explores how the mobile studio engineered a lifeline.

Crescent Energy's $1 billion stock offering, heavily anchored by KKR, reveals a structural shift in how North American shale consolidation is financed.

Health In Tech’s new HitRix platform uses AI to streamline stop-loss placement, but can it reverse the InsurTech's financial struggles and win over brokers?

Ahead of VF Corp's Q2 FY2027 earnings, all eyes are on Vans' turnaround efforts and The North Face's momentum as early indicators for holiday retail demand.

With CFIUS clearance secured, Clear Channel Outdoor's $6.2B acquisition by Mubadala Capital signals a new era for digital out-of-home advertising.

An inside look at how Pure Capital Group leveraged Israeli corporate law and financial vulnerabilities to seize control of an AI biotech pioneer without a buyout.